ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,261, issued on Dec. 2, was assigned to Terns Pharmaceuticals Inc. (Foster City, Calif.).
"Compounds as GLP-1R agonists" was invented by Corey Reeves (Foster City, Calif.), F. Anthony Romero (Redwood City, Calif.), Christopher T. Jones (Foster City, Calif.), Martijn Fenaux (San Mateo, Calif.) and Gary W. Luehr (Foster City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides compounds that may be used as a glucagon-like peptide-1 receptors (GLP-1R) agonist, or pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions containing such compounds, or pharmaceutically acceptable salts thereo...